Lumida
/LCTX
⌘K
Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc

LCTX
$1.01USD-0.98%-0.01 today

MARKET CAP

255.4M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$4.3M$14.7M$8.9M$9.5M$14.6M
YoY %+137.7%+238.7%-39.2%+6.2%+53.2%
P / Sales92.8x14.2x21.0x10.6x26.4x
EV / Sales99.3x17.0x21.4x9.6x28.4x
Gross Profit, Adj.$2.9M$14.0M$8.3M$9.5M$14.6M
YoY %+102.3%+379.4%-40.8%+14.8%+53.2%
Margin %67.2%95.0%92.5%100.0%100.0%
EV / Gross Profit147.8x17.8x23.2x9.6x28.4x
EBITDA, Adj.$-48.3M$-21.8M$-24.0M$-20.9M$-21.1M
YoY %-97.0%+54.9%-10.3%+13.2%-1.0%
Margin %-1113.5%-148.2%-268.8%-219.7%-144.8%
EV / EBITDA-8.9x-11.4x-8.0x-4.4x-19.6x
EBIT$-49.2M$-22.5M$-24.7M$-21.5M$-36.6M
YoY %-86.1%+54.2%-9.8%+13.2%-70.5%
Margin %-1133.6%-153.2%-276.5%-226.1%-251.6%
EV / EBIT-8.8x-11.1x-7.8x-4.2x-11.3x
Net Income$-43.0M$-26.3M$-21.5M$-18.6M$-63.5M
YoY %-108.3%+38.9%+18.2%+13.4%-241.4%
Net Margin-991.0%-178.7%-240.2%-195.9%-436.5%
EPS (GAAP)-$0.26-$0.15-$0.12-$0.09-$0.28
YoY %-85.7%+42.3%+20.0%+25.0%-211.1%